Published • loading... • Updated
McKesson, CD&R Near $5 Billion-Plus Deal to Buy Option Care, FT Reports
The acquisition would expand McKesson’s healthcare services footprint as Option Care shares rose 21% in extended trading, according to the report.
Summary by WTVB
Podcasts & Opinions
9 Articles
9 Articles
McKesson, CD&R near $5 billion-plus deal to buy Option Care ...
·London, United Kingdom
Read Full Article
Option Care Health Jumps 33 Percent to $31 After McKesson and CD&R Agree to Take It Private for $5.8 Billion
Option Care Health shares jumped 33% after McKesson and Clayton Dubilier & Rice agreed to take the infusion-therapy company private for about $5.8 billion, including debt.
·New York, United States
Read Full Article
McKesson and CD&R close in on $5bn-plus acquisition of Option Care Health
McKesson and Clayton Dubilier & Rice are nearing an agreement to acquire Option Care Health, the largest independent provider of infusion services in the US, in a transaction that would value the healthcare company at more than $5bn including debt, according to a report by the Financial Times.
Coverage Details
Total News Sources9
Leaning Left0Leaning Right2Center3Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
C 60%
R 40%
Factuality
To view factuality data please Upgrade to Premium
